Reaction Details |
| Report a problem with these data |
Target | Glycogen synthase kinase-3 alpha |
---|
Ligand | BDBM205261 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | GSK 3α Enzyme Inhibition Assay |
---|
IC50 | >1560±n/a nM |
---|
Citation | Duffy, LA; King-Underwood, J; Longshaw, AI; Murray, PJ; Onions, ST; Taddei, DM; Williams, JG; Ito, K; Charron, CE Pyrazole derivatives as p38 MAP inhibitors US Patent US9249125 Publication Date 2/2/2016 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Glycogen synthase kinase-3 alpha |
---|
Name: | Glycogen synthase kinase-3 alpha |
Synonyms: | GSK-3 alpha | GSK3A | GSK3A_HUMAN | Glycogen synthase kinase 3 alpha (GSKalpha) | Glycogen synthase kinase-3 | Glycogen synthase kinase-3 alpha | Glycogen synthase kinase-3 alpha (GSK3 Alpha) | Glycogen synthase kinase-3 alpha (GSK3A) | Glycogen synthase kinase-3 alpha (GSK3alpha) |
Type: | Enzyme |
Mol. Mass.: | 50991.79 |
Organism: | Homo sapiens (Human) |
Description: | P49840 |
Residue: | 483 |
Sequence: | MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGV
GASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYT
DIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFY
SSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGV
CHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSS
IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK
AHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLP
PLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLT
NSS
|
|
|
BDBM205261 |
---|
n/a |
---|
Name | BDBM205261 |
Synonyms: | US9249125, 13 |
Type | Small organic molecule |
Emp. Form. | C35H32N10O3 |
Mol. Mass. | 640.6938 |
SMILES | COc1ccc(cn1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc4[nH]ncc4c3)n2)c2ccccc12)C(C)(C)C |
Structure |
|